
|Articles|September 23, 2022
- September 2022
- Volume 88
- Issue 09
Pet Peeves: September 2022
Brought to you by The Sassy Pharmacist
Advertisement
Fourth Time’s the Charm
The pharmacist triple-counts the medication, and the patient recounts it in the drive-through.
Ignored Advice
Patients who ask for a recommendation and then buy something else.
Wrong Number
Patients who call the pharmacy asking about front-of-store items.
What’s Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to [email protected]. We’ll share them here and online.
Articles in this issue
almost 4 years ago
Adlarity From Coriumalmost 4 years ago
Generic Product News: September 2022almost 4 years ago
Pharmacists Are Empowered Yet Againalmost 4 years ago
Rx Products News: September 2022almost 4 years ago
OTC Cases: September 2022almost 4 years ago
ABM Offers Opportunity for Professional Growthalmost 4 years ago
Court Addresses Liability in Dispensing Controlled Substancesalmost 4 years ago
Mitigate Risk for Errors Involving Paxlovidalmost 4 years ago
OTC Products: September 2022Advertisement
Related to this article

Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.

With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.

Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.

Pharmacists rethink retirement: use compound growth, start early, and define the life you want—so your savings plan fits your future.

Lurking under the surface of inroads made toward better reimbursement and
expanded scope of practice are major workforce supply challenges.

New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.

Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
2
From Reactive to Proactive: AI's Role in Modern Pharmacy Safety
3
Trial Ended Early When Venetoclax Plus DA-EPOCH-R Did Not Improve Outcomes in Double-Hit Lymphoma
4
Pharmacists' Role as Ketone Monitoring Reaches Clinics
5

